MNA
RVMD icon

Manning & Napier Advisors’s Revolution Medicines RVMD Stock Holding History

Manning & Napier Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01K Buy
+26
New +$3.8K ﹤0.01% 593

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Manning & Napier Advisors's RVMD Position: Q2 2026 in Review

Manning & Napier Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 26 shares worth $5.01K. The stake represents ﹤0.01% of the portfolio and ranks #593 among its holdings.

688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Manning & Napier Advisors held 26 shares of Revolution Medicines worth $5.01K as of Q2 2026.
  • Revolution Medicines was a new Manning & Napier Advisors position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #593 holding.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.